Gestational diabetes & diabetes in pregnancy
Healthcare costs attributable to diabetes in pregnancy: A cost of illness study in Tasmania, Australia
Authors' conclusion
Our results emphasised the importance of proper management of diabetes in pregnancy in the prenatal and postpartum periods and highlighted the significance of screening and preventative strategies for diabetes in pregnancy.
Study context
- Population
- Delivery episodes in a population-based dataset, Tasmania, Australia, 2004–2017delivery episodes
- Participants
- 2,774 / 2,774 / 237
- Exposure
- Gestational diabetes mellitus (GDM) vs no diabetes in pregnancy
- GDMn = 2,774
- No diabetesn = 2,774reference
- Pre-existing diabetesn = 237
- Outcome
- Direct costs (hospitalisation, ED and pathology) during prenatal, delivery and postpartum periods, in 2020-2021 Australian dollars
- Follow-up
- 24-month period
Methodological detailspopulation-based, matched
- Population-based
- Matched
Main finding
As reported in the abstract
Incremental costs, year preceding delivery
$890
95% CI 635–1160P < 0.05
GDM
Incremental costs, delivery period
$812
95% CI 616–1031P < 0.05
GDM
Incremental costs, year following delivery
$341
95% CI 110–582P < 0.05
GDM
Pre-existing diabetes
$23,536/person
GDM
$13,210/person
No diabetes
$11,167/person
Observational data: associations, not effects.
Further findings
Incremental costs in the prenatal period (within the year preceding delivery)
- Incremental costs in the prenatal period, $ (95% CI)
- $803 (579; 1058) (p < 0.05)
Incremental costs in the postpartum period (within the year following delivery)
- Incremental costs in the postpartum period, $ (95% CI)
- $137 (55; 238) (p < 0.05)
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →